Clinical Trial Update: A Study to Assess Vamorolone in Becker Muscular Dystrophy (BMD) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating vamorolone for Becker muscular dystrophy has completed. The study was sponsored by ReveraGen BioPharma, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Becker Muscular Dystrophy

Drugs mentioned

• Vamorolone (vamorolone)

Snippet

Sponsor: ReveraGen BioPharma, Inc. | Conditions: Becker Muscular Dystrophy | Phase 2 | Status: COMPLETED